It’s less of a biological problem and more of a statistical sampling problem. The chances of there being a CoV antigen in the small drop of blood that you’d measure with a glucose monitor is very small. Sure, it might work, and the theory behind the device is sound. However, if you had a negative test, you’d never know if it was because you didn’t have CoV or if you just didn’t have any in that small blood sample.
I’d be happy to be wrong about this. A quick blood check as opposed to a 15min (the Abbott test) or 24hr (to 1 week with this backlog) wait would be amazing. But the amount of validation you’d need to demonstrate effectiveness would be equally amazing.
Given that the above test is some random marketing PDF and I haven't heard anyone respectable talk about this mechanism, I don't have much faith in it, so that is consistent with your analysis.
https://www.amazon.com/GenUltimate-Blood-Glucose-Strips-Mete...
Unless they are somehow using a glucose meter to monitor more blood than a finger stick?
I’m not doubting that you could have a test that worked by scanning for Coronavirus antigen in blood. But not with the device described here. But even assuming it worked, I don’t see how it would be better than an RNA amplification test.